Great Point files 5.17% stake in AMANAT

AMANAT ACQUISITION CORP ownership disclosure: Great Point Partners, LLC and two affiliated reporting persons report shared beneficial ownership of 500,000 Class A ordinary shares, equal to 5.17% of the class.

Rhea-AI Filing Summary

AMANAT ACQUISITION CORP ownership disclosure: Great Point Partners, LLC and two affiliated reporting persons report shared beneficial ownership of 500,000 Class A ordinary shares, equal to 5.17% of the class. The percentage is calculated using 9,675,000 shares outstanding reported in the issuer's May 20, 2026 prospectus. Great Point states it is investment manager of two record holders holding 330,000 and 170,000 shares respectively and disclaims beneficial ownership except for pecuniary interests. The filing is submitted jointly under a Joint Filing Agreement.

Insights

Corporate Governance Lawyer

Joint 13G filing reports a passive >5% stake and manager attribution.

The filing shows Great Point Partners, together with Dr. Jeffrey R. Jay and Ms. Lillian Nordahl, report shared beneficial ownership of 500,000 shares or 5.17% based on 9,675,000 shares outstanding as disclosed in the prospectus.

This is structured as a manager attribution: Great Point is investment manager to BVF and BOVF (holders of 330,000 and 170,000 shares). The reporting persons include a Joint Filing Agreement and disclaim direct beneficial ownership except to pecuniary interest.

Fund Compliance Officer

Disclosure aligns with passive investor reporting norms under Rule 13d-1.

The statement identifies voting and dispositive powers as shared for 500,000 shares and cites the prospectus figure for outstanding shares. The document attaches a jointly executed filing agreement dated May 27, 2026.

Key compliance items to verify in subsequent filings: confirm whether the position remains passive (13G) or converts to active reporting (13D) and ensure any changes in holdings or voting arrangements are promptly amended.

Key Figures

Reported shares beneficially owned: 500,000 shares Percent of class: 5.17% Shares outstanding used for calculation: 9,675,000 shares +2 more

5 metrics

Reported shares beneficially owned 500,000 shares Amount reported by Great Point and the two reporting persons

Percent of class 5.17% Calculated using prospectus outstanding shares

Shares outstanding used for calculation 9,675,000 shares Issuer figure from Form 424B prospectus dated May 20, 2026

BVF record ownership 330,000 shares Biomedical Value Fund, L.P. record holder amount

BOVF record ownership 170,000 shares Biomedical Offshore Value Fund, Ltd. record holder amount

Key Terms

Schedule 13G, beneficial ownership, investment manager, Joint Filing Agreement

4 terms

Schedule 13G regulatory

"Joint Filing Statement pursuant to Rule 13d-1(k)"

A Schedule 13G is a formal document that investors file with the government when they acquire a large ownership stake in a company, usually for investment purposes rather than control. It helps keep the public informed about who owns significant parts of a company's shares, which can influence how the company is managed and how investors make decisions. Filing this schedule is important for transparency and understanding the ownership landscape of publicly traded companies.

beneficial ownership financial

"Amount beneficially owned: 500,000"

Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.

investment manager financial

"Great Point is the investment manager of BVF and BOVF"

Joint Filing Agreement regulatory

"Joint Filing Agreement, dated May 27, 2026"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the AMAN Schedule 13G filed by Great Point Partners disclose?

It discloses shared beneficial ownership of 500,000 Class A ordinary shares representing 5.17% of the class, using 9,675,000 shares outstanding reported in the prospectus. It notes Great Point manages record holders that hold specified shares.

Who are the reporting persons in the AMAN filing (AMAN)?

The filing is by Great Point Partners, LLC, Dr. Jeffrey R. Jay, M.D., and Ms. Lillian Nordahl, who executed a Joint Filing Agreement dated May 27, 2026 to file jointly under Rule 13d-1(k)(1).

How is the 5.17% ownership calculated in the filing for AMAN?

The percentage is based on the issuer's prospectus figure of 9,675,000 shares outstanding as reported on May 20, 2026, with the reporting persons beneficially owning 500,000 shares for the 5.17% figure.

Does Great Point Partners claim direct beneficial ownership of all reported shares in AMAN?

No. Great Point disclaims beneficial ownership of the BVF and BOVF record holdings except to the extent of any pecuniary interest, while noting it is the investment manager for those record holders owning specified shares.

Which record holders and share amounts are referenced in the AMAN disclosure?

The filing identifies Biomedical Value Fund, L.P. as record holder of 330,000 shares and Biomedical Offshore Value Fund, Ltd. as record holder of 170,000 shares, with Great Point as their investment manager.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/27/2026 - 04:00 PM EDT Learn about SEC filing dates

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

AMANAT ACQUISITION CORP

(Name of Issuer)

Class A ordinary shares

(Title of Class of Securities)

G0375M101

(CUSIP Number)

05/19/2026

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

schemaVersion:

SCHEDULE 13G

CUSIP Number(s): G0375M101

1

Names of Reporting Persons

Great Point Partners, LLC

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 500,000.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 500,000.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

500,000.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

5.17 %

12

Type of Reporting Person (See Instructions)

IA, OO

SCHEDULE 13G

CUSIP Number(s): G0375M101

1

Names of Reporting Persons

Dr. Jeffrey R. Jay, M.D.

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

UNITED STATES

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 500,000.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 500,000.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

500,000.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

5.17 %

12

Type of Reporting Person (See Instructions)

HC, IN

SCHEDULE 13G

CUSIP Number(s): G0375M101

1

Names of Reporting Persons

Ms. Lillian Nordahl

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

UNITED STATES

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 500,000.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 500,000.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

500,000.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

5.17 %

12

Type of Reporting Person (See Instructions)

HC, IN

SCHEDULE 13G

Item 1.
(a)	Name of issuer: AMANAT ACQUISITION CORP
(b)	Address of issuer's principal executive offices: 153 Central Avenue, C/O 56, Westfield, NJ 07091
Item 2.
(a)	Name of person filing: Great Point Partners, LLC Dr. Jeffrey R. Jay, M.D. Ms. Lillian Nordahl The Reporting Persons have entered into a Joint Filing Agreement, dated May 27, 2026, a copy of which is filed with this SCHEDULE 13G as Exhibit A, pursuant to which the Reporting Persons have agreed to file this statement jointly in accordance with the provisions of Rule 13d-1(k)(1) under the Act.
(b)	Address or principal business office or, if none, residence: The address of the principal business office of each of the Reporting Persons is 165 Mason Street, 3rd Floor Greenwich, CT 06830
(c)	Citizenship: Great Point Partners, LLC is a limited liability company organized under the laws of the State of Delaware. Dr. Jeffrey R. Jay, M.D. is a citizen of the United States. Ms. Lillian Nordahl is a citizen of the United States.
(d)	Title of class of securities: Class A ordinary shares
(e)	CUSIP Number(s): G0375M101
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: 500,000
(b)	Percent of class: 5.17%
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: 0
	(ii) Shared power to vote or to direct the vote: 500,000
	(iii) Sole power to dispose or to direct the disposition of: 0
	(iv) Shared power to dispose or to direct the disposition of: 500,000 Item 4 The information required by Items 4(a) - (c) is set forth in Rows (5) - (11) of the cover pages for the Reporting Persons and is incorporated herein by reference. The percentage set forth in Row (11) of the cover pages for the Reporting Persons are based on a total of 9,675,000 shares outstanding, as reported by the Issuer in its Form 424B Prospectus filed with the Securities and Exchange Commission (the "SEC") on May 20, 2026. Biomedical Value Fund, L.P. ("BVF") is the record holder of 330,000 shares of Class A Ordinary Shares (the "BVF Shares"). Great Point Partners, LLC ("Great Point") is the investment manager of BVF, and by virtue of such status may be deemed to be the beneficial owner of the BVF Shares. Each of Dr. Jeffrey R. Jay, M.D. ("Dr. Jay"), as Senior Managing Member of Great Point, and Ms. Lillian Nordahl ("Ms. Nordahl"), as Managing Director of Great Point, has voting and investment power with respect to the BVF Shares, and therefore may be deemed to be the beneficial owner of the BVF Shares. Biomedical Offshore Value Fund, Ltd. ("BOVF") is the record holder of 170,000 shares of Class A Ordinary Shares (the "BOVF Shares"). Great Point is the investment manager of BOVF, and by virtue of such status may be deemed to be the beneficial owner of the BOVF Shares. Each of Dr. Jeffrey R. Jay, M.D. ("Dr. Jay"), as Senior Managing Member of Great Point, and Ms. Lillian Nordahl ("Ms. Nordahl"), as Managing Director of Great Point, has voting and investment power with respect to the BOVF Shares, and therefore may be deemed to be the beneficial owner of the BOVF Shares. Notwithstanding the above, Great Point, Dr. Jay and Ms. Nordahl disclaim beneficial ownership of the BVF Shares and the BOVF Shares, except to the extent of their respective pecuniary interests.
Item 5.	Ownership of 5 Percent or Less of a Class.
	Not Applicable
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	If any other person is known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, such securities, a statement to that effect should be included in response to this item and, if such interest relates to more than 5 percent of the class, such person should be identified. A listing of the shareholders of an investment company registered under the Investment Company Act of 1940 or the beneficiaries of employee benefit plan, pension fund or endowment fund is not required. See Item 4.
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Great Point Partners, LLC

Signature:	/s/ Dr. Jeffrey R. Jay, M.D
Name/Title:	Dr. Jeffrey R. Jay, M.D - Senior Managing Member
Date:	05/27/2026

Dr. Jeffrey R. Jay, M.D.

Signature:	/s/ Dr. Jeffrey R. Jay, M.D
Name/Title:	Dr. Jeffrey R. Jay, M.D
Date:	05/27/2026

Ms. Lillian Nordahl

Signature:	/s/ Ms. Lillian Nordahl
Name/Title:	Ms. Lillian Nordahl
Date:	05/27/2026

Exhibit Information

JOINT FILING STATEMENT PURSUANT TO RULE 13d-1(k) The undersigned hereby agree as follows: (i) Each of them is individually eligible to use the SCHEDULE 13G to which this Exhibit is attached, and such SCHEDULE 13G is filed on behalf of each of them; and (ii) Each of them is responsible for the timely filing of such SCHEDULE 13G and any amendments thereto, and for the completeness and accuracy of the information concerning such person contained therein; but none of them is responsible for the completeness or accuracy of the information concerning the other persons making the filing, unless such person knows or has reason to believe that such information is inaccurate. Dated: May 27, 2026 Great Point Partners, LLC By: /s/ Dr. Jeffrey R. Jay, M.D. Dr. Jeffrey R. Jay, M.D., as Senior Managing Member Dr. Jeffrey R. Jay, M.D. By: /s/ Dr. Jeffrey R. Jay, M.D. Dr. Jeffrey R. Jay, M.D. Ms. Lillian Nordahl By: /s/ Ms. Lillian Nordahl Ms. Lillian Nordahl